Details for New Drug Application (NDA): 062383
✉ Email this page to a colleague
NDA 062383 describes NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN, which is a drug marketed by Pharmafair and is included in one NDA. Additional details are available on the NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN profile page.
The generic ingredient in NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
The generic ingredient in NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN is gramicidin; neomycin sulfate; polymyxin b sulfate. There are five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the gramicidin; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 062383
| Tradename: | NEOMYCIN SULFATE AND POLYMYXIN B SULFATE GRAMICIDIN |
| Applicant: | Pharmafair |
| Ingredient: | gramicidin; neomycin sulfate; polymyxin b sulfate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION/DROPS;OPHTHALMIC | Strength | 0.025MG/ML;EQ 1.75MG BASE/ML;10,000 UNITS/ML | ||||
| Approval Date: | Aug 31, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
